by Proxiva Peptides | Mar 4, 2026 | Research Guides
Introduction: The Biology of Fatigue and Energy Metabolism Chronic fatigue is one of the most common complaints in modern medicine, affecting an estimated 20-30% of the general population at any given time. Beyond ordinary tiredness, pathological fatigue represents a...
by Proxiva Peptides | Mar 4, 2026 | Research Guides
Introduction: Brain Fog and Cognitive Enhancement Research Brain fog — characterized by difficulty concentrating, mental fatigue, poor memory recall, reduced mental clarity, and slowed cognitive processing — affects millions of people and has become increasingly...
by Proxiva Peptides | Mar 4, 2026 | Research Guides
Introduction: Gastrointestinal Disorders and Peptide Research Irritable bowel syndrome (IBS) affects an estimated 10-15% of the global population, making it one of the most prevalent functional gastrointestinal disorders. Beyond IBS, conditions including inflammatory...
by Proxiva Peptides | Mar 4, 2026 | Research Guides
Introduction: Tendonitis and the Limits of Current Treatment Tendonitis — more accurately termed tendinopathy to encompass the broader spectrum of tendon disorders — affects millions of people worldwide and represents one of the most common musculoskeletal conditions...
by Proxiva Peptides | Mar 4, 2026 | Research Guides
Introduction: Back Pain and the Research Peptide Landscape Back pain is the single leading cause of disability worldwide, affecting approximately 80% of adults at some point during their lifetime. Low back pain alone accounts for more years lived with disability than...
by Proxiva Peptides | Mar 4, 2026 | Research Guides
Introduction: Knee Pain and the Peptide Research Frontier Knee pain affects an estimated 25% of the adult population and represents one of the most common musculoskeletal complaints worldwide. The knee joint’s complex anatomy — comprising articular cartilage,...
